155 related articles for article (PubMed ID: 24719449)
1. Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.
Wheat LJ; Nguyen MH; Alexander BD; Denning D; Caliendo AM; Lyon GM; Baden LR; Marty FM; Clancy C; Kirsch E; Noth P; Witt J; Sugrue M; Wingard JR
J Clin Microbiol; 2014 Jun; 52(6):2108-11. PubMed ID: 24719449
[TBL] [Abstract][Full Text] [Related]
2. Insufficient demonstration of long-term stability of Aspergillus galactomannan.
Johnson GL; Sarker SJ; Bustin SA; Agrawal SG
J Clin Microbiol; 2014 Nov; 52(11):4118. PubMed ID: 25324240
[No Abstract] [Full Text] [Related]
3. Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan".
Wheat LJ; Nguyen MH; Alexander BD; Denning D; Caliendo AM; Lyon GM; Baden LR; Marty FM; Clancy C; Kirsch E; Noth P; Witt J; Sugrue M; Wingard JR
J Clin Microbiol; 2014 Nov; 52(11):4119. PubMed ID: 25324241
[No Abstract] [Full Text] [Related]
4. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.
Husain S; Clancy CJ; Nguyen MH; Swartzentruber S; Leather H; LeMonte AM; Durkin MM; Knox KS; Hage CA; Bentsen C; Singh N; Wingard JR; Wheat LJ
Clin Vaccine Immunol; 2008 Dec; 15(12):1760-3. PubMed ID: 18845830
[TBL] [Abstract][Full Text] [Related]
5. Instability of Aspergillus galactomannan in stored clinical samples.
Dufresne SF; Beauchemin S; Lavallée C; Laverdière M
J Clin Microbiol; 2014 Dec; 52(12):4435-6. PubMed ID: 25253794
[No Abstract] [Full Text] [Related]
6. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.
Torelli R; Sanguinetti M; Moody A; Pagano L; Caira M; De Carolis E; Fuso L; De Pascale G; Bello G; Antonelli M; Fadda G; Posteraro B
J Clin Microbiol; 2011 Dec; 49(12):4273-8. PubMed ID: 22012015
[TBL] [Abstract][Full Text] [Related]
7. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.
Izumikawa K; Yamamoto Y; Mihara T; Takazono T; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yanagihara K; Mine M; Yasuoka A; Tashiro T; Kohno S
Med Mycol; 2012 Nov; 50(8):811-7. PubMed ID: 22568603
[TBL] [Abstract][Full Text] [Related]
9. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
[TBL] [Abstract][Full Text] [Related]
10. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
14. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.
Heng SC; Morrissey O; Chen SC; Thursky K; Manser RL; Nation RL; Kong DC; Slavin M
Crit Rev Microbiol; 2015 Feb; 41(1):124-34. PubMed ID: 23799871
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management.
Penack O; Rempf P; Graf B; Blau IW; Thiel E
Ann Oncol; 2008 May; 19(5):984-9. PubMed ID: 18227109
[TBL] [Abstract][Full Text] [Related]
16. Utility of Aspergillus antigen detection in specimens other than serum specimens.
Klont RR; Mennink-Kersten MA; Verweij PE
Clin Infect Dis; 2004 Nov; 39(10):1467-74. PubMed ID: 15546083
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment of Bronchoalveolar Lavage Fluid Samples with SLsolution Leads to False-Negative Aspergillus Galactomannan Levels.
Gils S; Maertens J; Lagrou K
J Clin Microbiol; 2016 Apr; 54(4):1171. PubMed ID: 26763955
[No Abstract] [Full Text] [Related]
19. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.
Wheat LJ; Walsh TJ
Eur J Clin Microbiol Infect Dis; 2008 Apr; 27(4):245-51. PubMed ID: 18193305
[TBL] [Abstract][Full Text] [Related]
20. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
Vergidis P; Razonable RR; Wheat LJ; Estes L; Caliendo AM; Baden LR; Wingard JR; Baddley J; Assi M; Norris S; Chandrasekar P; Shields R; Nguyen H; Freifeld A; Kohler R; Kleiman M; Walsh TJ; Hage CA
J Clin Microbiol; 2014 Jun; 52(6):2199-201. PubMed ID: 24719434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
